Novavax said Tuesday that it would cut around a quarter of its workforce as it reported a steeper fall in revenue than expected for the first quarter of the year. Shares surged as investors bet the move could save enough money to to allow the Covid-19 vaccine manufacturer to bring new shots to the market.

